{"id":"NCT04659863","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia","officialTitle":"Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol (ORION-13)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-02-16","primaryCompletion":"2023-10-30","completion":"2024-11-18","firstPosted":"2020-12-09","resultsPosted":"2025-05-31","lastUpdate":"2025-05-31"},"enrollment":13,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Familial Hypercholesterolemia - Homozygous"],"interventions":[{"type":"DRUG","name":"Inclisiran","otherNames":["KJX839"]},{"type":"DRUG","name":"Placebo","otherNames":["Saline solution"]}],"arms":[{"label":"Part 1 - Inclisiran","type":"EXPERIMENTAL"},{"label":"Part 1 - Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Part 2 - Inclisiran (Total)","type":"EXPERIMENTAL"}],"summary":"This was a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in adolescents with homozygous familial hypercholesterolemia (HoFH) and elevated low density lipoprotein cholesterol (LDL-C).","primaryOutcome":{"measure":"Percentage Change in LDL-C From Baseline to Day 330 (Part 1/Year 1)","timeFrame":"Baseline and Day 330","effectByArm":[{"arm":"Part 1- Inclisiran","deltaMin":-21.6,"sd":13.36},{"arm":"Part 1 - Placebo","deltaMin":11.7,"sd":30.52}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":11,"countries":["United States","Canada","France","Greece","Lebanon","Malaysia","Netherlands","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["40391436","35175352","33990512"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":9},"commonTop":["COVID-19","Abdominal pain upper","Influenza like illness","Injection site erythema","Injection site reaction"]}}